Every SEC Form 3/4/5 on record for this filer (CIK 1131399) — 26 issuers, 72 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
3 filings failed a price guard — listed below with the reason, excluded from the totals above.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 10% owner | 2023-01-30 → 2025-12-15 | 4 | $67M |
| SPRO | Spero Therapeutics, Inc. | 10% owner · lapsed | 2017-11-02 → 2022-11-14 | 4 | $7M |
| ME | 23andMe Holding Co. | 10% owner · lapsed | 2022-11-04 → 2022-11-04 | 1 | — |
| TBPH | Theravance Biopharma, Inc. | Filer · lapsed | 2015-10-07 → 2022-09-20 | 4 | — |
| CVRX | CVRx, Inc. | 10% owner · lapsed | 2021-07-06 → 2021-07-06 | 2 | $5M |
| LYEL | Lyell Immunopharma, Inc. | 10% owner · lapsed | 2021-06-17 → 2021-06-23 | 2 | — |
| INVA | Innoviva, Inc. | 10% owner · lapsed | 2021-05-24 → 2021-05-24 | 1 | −$392M |
| DBTX | Decibel Therapeutics, Inc. | Director · lapsed | 2021-02-11 → 2021-02-19 | 2 | $3M |
| BCYC | BICYCLE THERAPEUTICS PLC | 10% owner · lapsed | 2019-05-23 → 2020-09-18 | 3 | $5M |
| GNCA | GENOCEA BIOSCIENCES, INC. | 10% owner · lapsed | 2019-02-25 → 2020-07-30 | 3 | $9M |
| PAND | Pandion Therapeutics, Inc. | Director · lapsed | 2020-07-16 → 2020-07-22 | 2 | $6M |
| NKTX | Nkarta, Inc. | Director · lapsed | 2020-07-09 → 2020-07-16 | 3 | $15M |
| TPTX | Turning Point Therapeutics, Inc. | Director · lapsed | 2019-04-16 → 2020-05-26 | 4 | $19M |
| PGNY | Progyny, Inc. | 10% owner · lapsed | 2019-10-24 → 2020-05-21 | 3 | −$103M |
| ORTX | Orchard Therapeutics plc | Director · lapsed | 2020-01-02 → 2020-01-02 | 1 | — |
| PRNB | Principia Biopharma Inc. | Filer · lapsed | 2018-09-13 → 2019-10-22 | 5 | $15M |
| FULC | Fulcrum Therapeutics, Inc. | 10% owner · lapsed | 2019-07-17 → 2019-07-24 | 2 | — |
| MORF | Morphic Holding, Inc. | Director · lapsed | 2019-06-26 → 2019-07-02 | 2 | $5M |
| CCXI | ChemoCentryx, Inc. | Filer · lapsed | 2018-10-18 → 2018-10-18 | 1 | −$86M |
| LQDA | Liquidia Corp | Filer · lapsed | 2018-07-25 → 2018-08-01 | 2 | $2M |
| CNST | CONSTELLATION PHARMACEUTICALS INC | 10% owner · lapsed | 2018-07-18 → 2018-07-18 | 1 | — |
| TBIO | Translate Bio, Inc. | 10% owner · lapsed | 2018-06-27 → 2018-07-03 | 2 | $3M |
| ALRN | AILERON THERAPEUTICS INC | 10% owner · lapsed | 2017-06-28 → 2017-06-28 | 1 | — |
| HTGM | HTG MOLECULAR DIAGNOSTICS, INC | Filer · lapsed | 2017-03-29 → 2017-03-30 | 2 | −$6M |
| CRSP | CRISPR Therapeutics AG | 10% owner · lapsed | 2016-10-18 → 2016-10-26 | 3 | $931,000 |
| THRX | THERAVANCE INC | 10% owner · lapsed | 2015-08-07 → 2015-08-07 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| WVE | 2025-12-11 | Buy | 1,470,000 | $19.00 | $28M | 18,245,691 |
| WVE | 2024-09-27 | Buy | 2,791,930 | $8.00 | $22M | 16,775,691 |
| WVE | 2023-12-07 | Buy | 3,300,000 | $5.00 | $17M | 13,983,761 |
| CVRX | 2021-07-02 | Buy | 275,000 | $18.00 | $5M | 1,007,583 |
11 of 26 issuers are covered and open a security page; the rest are on file here only.
